FDA approves two combination AIDS drugs delivered in a single pill form

08/3/2004 | USA Today · NYTimes.com

The FDA gave its approval to two combination AIDS drugs, making it more likely that patients in poor countries will have access to treatment through the U.S.' $15 billion emergency AIDS fund. Both pills combine two medicines into one pill to be taken once a day. Gilead Science's Truvada combines Viread and Emtriva and GlaxoSmithKline's Epzicom combines the company's HIV medicines Epivir and Ziagen.

View Full Article in:

USA Today · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC